In summary, previous studies showed that high levels of CD44 expression are associated with a number of factors that indicate a poorer prognosis, such as larger tumor size, more aggressive tumor grade, increased lymph node involvement, metastasis, and decreased survival. The gene discussed is CD44; the disease is neoplasm.